GlassScriptPhysician profile
James Tucker
NPI 1134548209
$5,856.96
in general payments reported to CMS, 2019-2025
20 companies · $901 in 2025
The $901 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $97.98 · 2021: $328 · 2022: $924 · 2023: $1,363 · 2024: $1,486 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,732 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,732.31 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,517.65 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Abbvie INC. | $579.46 | 2023-2025 | |
| Aerie Pharmaceuticals, INC. | $342.72 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $239.78 | 2024-2025 | Catalys System, Tecnis Simplicity, Tecnis Iol |
| Allergan, INC. | $174.28 | 2020-2022 | |
| Biotissue Holdings INC. | $156.05 | 2024-2025 | |
| Genentech USA, INC. | $150.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $120.80 | 2024-2025 | Xdemvy |
| Convatec INC. | $116.57 | 2024 | |
| Bausch & Lomb Americas INC. | $70.44 | 2023-2024 | Miebo, Scoutpro Osmolarity System |
| Rxsight INC | $63.89 | 2024-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Apellis Pharmaceuticals, INC. | $54.75 | 2024 | Syfovre |
| Harrow Eye, LLC | $54.41 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $53.47 | 2022-2023 | Tyrvaya |
| Amgen INC. | $45.42 | 2025 | Tepezza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $38.65 | 2023 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Horizon Therapeutics Plc | $27.07 | 2022 | |
| Sun Pharmaceutical Industries INC. | $21.35 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $15.70 | 2023 | Eylea |
| Thea Pharma INC. | $14.50 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.